• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

Mechanistic analysis of Ivermectin

June 19, 2020COVID-19, Vizit Graphs
Mechanistic analysis of IvermectinEftychia Lekka2020-08-03T13:55:41+00:00
Mechanistic analysis of Ivermectin

Ivermectin is an anti-parasitic agent that has shown promise against the virus in vitro. Its potential mechanism of action (MoA) in COVID-19, is poorly understood.

Explore the live graph.

Tags: A.R.D.S., ABCB1, ACE, ACE2, ALANINE AMINOTRANSFERASE, ALBUMIN, ANTIBODY FORMATION, ASPARTATE AMINOTRANSFERASE, BREATH SHORTNESS, COUGH, CRP, DIARRHEA, DISTRESS RESPIRATORY, IL10, IL1B, IL6, IMMUNITY, IMMUNOCOMPROMISED HOST, INFECTION, INFLAMMATION, INJURY, INTERFERON, ITCH, IVERMECTIN, LDH, LIFE CYCLE STAGES, LUNG INFLAMMATION, MUSCLE STRAIN, MYALGIA, PAIN, RESPIRATION, RNA DEPENDENT RNA POLYMERASE, SARS-COV-2, SPIKE, TNF

Post navigation

← Mechanistic analysis of combination IFB-a2b chlorpheniramine, ibuprofen
Mechanistic analysis of Azithromycin →

Vizit Graphs Tag Cloud

COVID-19 HELICOBACTER PYLORI INSULIN PSEUDOMONAS AERUGINOSA PD-1 ESCHERICHIA COLI ACE2 PARKINSON DISEASE CELL PROLIFERATION RAS METFORMIN TMPRSS2 ALBUMIN NEUTROPHILS MYALGIA IL6 IMMUNITY IL10 APOPTOTIC PROCESS CD4 LACTATE DEHYDROGENASE COAGULATION IFNG AGING TNF STAPHYLOCOCCUS AUREUS CASP3 IL2 LISTERIA MONOCYTOGENES IL1B ANGIOTENSIN II IMMUNE RESPONSE INFLAMMATION COGNITION INFLAMMATORY RESPONSE AUTOPHAGY INTERFERON CELL DIFFERENTIATION NFKB1 CANDIDA ALBICANS SARS-COV-2 ALZHEIMER'S DISEASE RHEUMATOID ARTHRITIS ACE CANCER

© 2021 Biovista Vizit All Rights Reserved.